Remarkably, activation of FGF‐R2 requires stromal‐dependent secretion of FGF7, the most specific ligand for FGF‐R2 (Wesche et al., 2011), resulting in a specific and spatial activation of FGF‐R2 signalling in tumour cells. The gene discussed is FGFR2; the disease is neoplasm.